Page last updated: 2024-11-03

opc 12759 and Colonic Neoplasms

opc 12759 has been researched along with Colonic Neoplasms in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kabeya, M1
Ina, K1
Yuasa, S1
Kikuchi, F1
Tajiri, C1
Kato, T1
Hibi, S1
Minagawa, Y1
Furuta, R1
Kayukawa, S1
Kataoka, T1
Kawai, M1
Niwa, Y1
Nakamura, M1
Omiya, N1
Itoh, A1
Hirooka, Y1
Goto, H1

Trials

1 trial available for opc 12759 and Colonic Neoplasms

ArticleYear
[Pilot study on clinical effects of rebamipide gargle against oral mucositis induced by fluoropyrimidines].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:7

    Topics: Alanine; Antimetabolites, Antineoplastic; Colonic Neoplasms; Fluorouracil; Humans; Mouthwashes; Pilo

2011

Other Studies

1 other study available for opc 12759 and Colonic Neoplasms

ArticleYear
Ileal cancer and erosions in the small intestine revealed by capsule endoscopy.
    Endoscopy, 2007, Volume: 39 Suppl 1

    Topics: Adenocarcinoma; Adenoma; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Capsule Endoscopy; Colonic N

2007